Birdwatch Note
2024-10-04 23:37:38 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
レプリコンワクチンは、免疫を引き起こすためのタンパク質のみを体内で作るので、完全なウイルスを作れず、他の細胞に感染させることはありません。そのため、体内で感染が広がったり、他人に感染するリスクもありません。 https://newspicks.com/news/10551966/body/
Written by D7A3BA93AB464C3619BF19A06DEEEC6CF1E9AFAE70B90D9D52109AB3CDAB4E0E
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1842233170370101438
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1842348385564791198
- noteId - 1842348385564791198
- participantId -
- noteAuthorParticipantId - D7A3BA93AB464C3619BF19A06DEEEC6CF1E9AFAE70B90D9D52109AB3CDAB4E0E
- createdAtMillis - 1728085058954
- tweetId - 1842233170370101438
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- レプリコンワクチンは、免疫を引き起こすためのタンパク質のみを体内で作るので、完全なウイルスを作れず、他の細胞に感染させることはありません。そのため、体内で感染が広がったり、他人に感染するリスクもありません。 https://newspicks.com/news/10551966/body/
Note Ratings
rated at | rated by | |
2024-10-04 20:00:04 -0500 | Rating Details | |
2024-10-04 19:46:47 -0500 | Rating Details | |
2024-10-04 19:44:45 -0500 | Rating Details | |
2024-10-04 19:43:30 -0500 | Rating Details | |
2024-10-04 19:39:40 -0500 | Rating Details | |
2024-10-04 19:39:03 -0500 | Rating Details | |
2024-10-04 19:38:49 -0500 | Rating Details | |
2024-10-04 19:38:34 -0500 | Rating Details | |
2024-10-04 19:37:59 -0500 | Rating Details | |
2024-10-04 19:36:55 -0500 | Rating Details | |
2024-10-04 19:33:41 -0500 | Rating Details | |
2024-10-04 19:31:24 -0500 | Rating Details | |
2024-10-04 19:26:09 -0500 | Rating Details | |
2024-10-04 19:20:05 -0500 | Rating Details | |
2024-10-04 19:18:09 -0500 | Rating Details | |
2024-10-04 19:17:29 -0500 | Rating Details | |
2024-10-04 19:15:53 -0500 | Rating Details | |
2024-10-04 19:13:02 -0500 | Rating Details | |
2024-10-04 19:10:41 -0500 | Rating Details | |
2024-10-04 19:05:34 -0500 | Rating Details | |
2024-10-04 19:03:27 -0500 | Rating Details | |
2024-10-04 19:01:44 -0500 | Rating Details | |
2024-10-04 19:01:43 -0500 | Rating Details | |
2024-10-04 19:00:26 -0500 | Rating Details | |
2024-10-04 18:58:33 -0500 | Rating Details | |
2024-10-06 05:28:36 -0500 | Rating Details | |
2024-10-05 16:34:57 -0500 | Rating Details | |
2024-10-05 10:55:43 -0500 | Rating Details | |
2024-10-05 05:35:01 -0500 | Rating Details | |
2024-10-05 03:28:04 -0500 | Rating Details | |
2024-10-04 22:36:57 -0500 | Rating Details | |
2024-10-04 20:56:55 -0500 | Rating Details | |
2024-10-04 20:51:14 -0500 | Rating Details | |
2024-10-04 20:10:21 -0500 | Rating Details | |
2024-10-04 19:40:32 -0500 | Rating Details | |
2024-10-04 19:16:09 -0500 | Rating Details | |
2024-10-04 19:16:03 -0500 | Rating Details | |
2024-10-04 19:14:15 -0500 | Rating Details | |
2024-10-04 19:06:44 -0500 | Rating Details | |
2024-10-04 18:57:19 -0500 | Rating Details | |
2024-10-10 07:08:28 -0500 | Rating Details | |
2024-10-07 02:19:38 -0500 | Rating Details | |
2024-10-06 23:22:51 -0500 | Rating Details | |
2024-10-06 04:25:44 -0500 | Rating Details | |
2024-10-05 03:32:28 -0500 | Rating Details | |
2024-10-04 23:54:51 -0500 | Rating Details | |
2024-10-04 23:44:57 -0500 | Rating Details | |
2024-10-04 23:28:19 -0500 | Rating Details | |
2024-10-04 22:37:49 -0500 | Rating Details | |
2024-10-04 21:14:09 -0500 | Rating Details | |
2024-10-04 20:29:12 -0500 | Rating Details | |
2024-10-04 19:59:06 -0500 | Rating Details | |
2024-10-04 18:49:07 -0500 | Rating Details | |
2024-10-04 23:26:29 -0500 | Rating Details | |
2024-10-04 23:18:29 -0500 | Rating Details | |
2024-10-04 23:01:53 -0500 | Rating Details | |
2024-10-04 22:35:03 -0500 | Rating Details | |
2024-10-04 22:34:57 -0500 | Rating Details | |
2024-10-04 22:22:21 -0500 | Rating Details | |
2024-10-04 21:51:32 -0500 | Rating Details | |
2024-10-04 20:21:47 -0500 | Rating Details | |
2024-10-04 20:21:13 -0500 | Rating Details | |
2024-10-04 19:32:29 -0500 | Rating Details | |
2024-10-04 19:20:47 -0500 | Rating Details | |
2024-10-04 19:18:02 -0500 | Rating Details | |
2024-10-27 02:20:06 -0500 | Rating Details |